To be honest, long term that doesn’t concern me, it’s CFDA approval that slightly concerns me at moment although I am still reasonably confident of approval.
Already over 6 months since being lodged and I believe that this whole publicised Aus/China relationship bust-up is definately impacting the decision time. Hopefully it only delays CFDA decision but doesn’t impact the decision itself but as a shareholder yes I am still slightly concerned.
BAL Price at posting:
$14.94 Sentiment: Hold Disclosure: Held
